REN and hypertensive disorder: Our own previous study also compared SAE rates in trial participants and patients in routine care finding higher rates in the routine care population after age-sex standardisation, but did so solely for trials of agents acting on the renin-angiotensin-aldosterone system in order to treat hypertension [9].